Susan Savage

Susan Savage serves as vice president of retail sales at Confirm Biosciences, where she leads national retail strategy and drives category growth across the country’s largest mass, drug, and grocery chains. In this role, she collaborates closely with leading retailers to expand distribution, optimize product placement, and bring innovative diagnostic solutions to consumers through trusted retail channels.

Confirm Biosciences plays a key role in several major diagnostic categories, including COVID/flu testing, drugs of abuse screening such as fentanyl detection, and private-label pregnancy tests. Under Savage’s retail leadership, the company has expanded its presence across national chains while helping retailers meet growing consumer demand for convenient at-home health testing products.

A significant milestone was reached when Confirm Biosciences became the first to introduce an FDA 510(k)-De Novo COVID/flu combination test to the market. This product marked a breakthrough in at-home diagnostics, enabling consumers to test for both viruses with a single device. The innovation gained national recognition and was named by ABC News as one of the top five medical ­breakthroughs.

Since April 2025, millions of the company’s COVID/flu tests have been sold nationwide, reflecting strong retail performance, expanded distribution, and increasing consumer trust.

Savage remains dedicated to expanding access to quality diagnostic tools through retail channels. Her efforts continue to position retailers as essential points for everyday healthcare, providing reliable at-home testing products to millions of American households.